Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Zealand Pharma A/S
Sponsor

Zealand Pharma A/S

Denmark Sydmarken 11, 2860 Soeborg, Denmark

About the sponsor

Clinical research in short bowel syndrome focuses on patients with intestinal failure, including studies assessing long-term treatment use, efficacy, and safety in this gastrointestinal disorder. The portfolio also includes work in SBS-IF populations.

  • Short bowel syndrome
  • Intestinal failure
  • Gastrointestinal disease management
  • Long-term treatment safety

Research activity in this area centers on therapies aimed at improving intestinal function and supporting chronic management of malabsorption-related disease.

About Specializations

Zealand Pharma A/S runs clinical trials in conditions such as Short-bowel syndrome, Weight control, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Short-bowel syndrome

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S

Weight control

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide
  • Sponsor:Zealand Pharma A/S

Short-bowel syndrome

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S

Long-term Safety Study of Dasiglucagon for Children with Congenital Hyperinsulinism

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Dasiglucagon
  • Sponsor:Zealand Pharma A/S

Short-bowel syndrome

Not recruiting
InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S

Short-bowel syndrome

Not recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.